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Changing the Antibiotic Prescribing of
general practice registrars: the ChAP study
protocol for a prospective controlled study
of a multimodal educational intervention
Mieke L. van Driel1*, Simon Morgan2, Amanda Tapley3, Lawrie McArthur4, Patrick McElduff5, Lucy Yardley6,
Anthea Dallas7, Laura Deckx1, Katie Mulquiney3, Joshua S. Davis5,8,9, Andrew Davey10, Kim Henderson3,
Paul Little11 and Parker J. Magin3,10

Abstract
Background: Australian General Practitioners (GPs) are generous prescribers of antibiotics, prompting concerns
including increasing antimicrobial resistance in the community. Recent data show that GPs in vocational training
have prescribing patterns comparable with the high prescribing rate of their established GP supervisors.
Evidence-based guidelines consistently advise that antibiotics are not indicated for uncomplicated upper respiratory
tract infections (URTI) and are rarely indicated for acute bronchitis. A number of interventions have been trialled to
promote rational antibiotic prescribing by established GPs (with variable effectiveness), but the impact of such
interventions in a training setting is unclear. We hypothesise that intervening while early-career GPs are still
developing their practice patterns and prescribing habits will result in better adherence to evidence-based
guidelines as manifested by lower antibiotic prescribing rates for URTIs and acute bronchitis.
Methods/design: The intervention consists of two online modules, a face-to-face workshop for GP trainees, a
face-to-face workshop for their supervisors and encouragement for the trainee-supervisor dyad to include a
case-based discussion of evidence-based antibiotic prescribing in their weekly one-on-one teaching meetings.
We will use a non-randomised, non-equivalent control group design to assess the impact on antibiotic
prescribing for acute upper respiratory infections and acute bronchitis by GP trainees in vocational training.
Discussion: Early-career GPs who are still developing their clinical practice and prescribing habits are an
underutilized target-group for interventions to curb the growth of antimicrobial resistance in the community.
Interventions that are embedded into existing training programs or are linked to continuing professional
development have potential to increase the impact of existing interventions at limited additional cost.
Trial registration: Australian New Zealand Clinical Trials Registry, ACTRN12614001209684 (registered 17/11/2014).
Keywords: Antibacterial agents, Drug resistance, Evidence-based medicine, General practice, Graduate medical
education, Physician prescribing patterns
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Background
Antimicrobial resistance is a serious and increasing
threat to global public health and it is linked to the
over-prescription of antibiotics [1, 2]. The majority of
antibiotics consumed by humans are prescribed in primary care [2, 3], and they are often prescribed in conditions for which there is no evidence of benefit [4, 5]. For
example, initial use of antibiotics is not of benefit in
acute upper respiratory tract infections (URTIs) and is
associated with an increase in adverse effects [6]. For
acute bronchitis, antibiotics are associated with limited
benefits of doubtful clinical significance [4].
Evidence-based therapeutic guidelines are widely used
in general practice. The “Australian Therapeutic Guidelines: Antibiotic v15” for example recommend symptomatic (non-antibiotic) treatment for acute uncomplicated
URTIs and advise that acute bronchitis is most often
viral and usually does not require antibiotic therapy [7].
Availability and knowledge of guidelines, however, does
not guarantee adherence which is reflected in the level
of over-prescribing of antibiotics [8]. Data from Australian general practitioners (GPs) in training showed that
antibiotics are prescribed in 22 % of presentations for
URTIs, and 73 % of bronchitis/bronchiolitis [9]. These
prescription rates are comparable to those of established
GPs. This clear overprescribing of antibiotics suggests
that more effort needs to be directed towards changing
the prescribing habits of clinicians.
In high-income countries, public campaigns at a regional and national level using a variety of multimedia
platforms, have been directed at the public, child-care
staff and health professionals [10]. Most campaigns also
encouraged the use of guidelines in the components that
targeted prescribers. Results from some multifaceted
campaigns repeated over several years suggest a positive
effect on antibiotic use, but others seem to have had little if any effect [10]. The means by which the prescribing
patterns of GPs might be influenced is still the focus of
debate. In primary care, a variety of interventions aimed
at influencing individual doctors’ prescribing have been
studied, including audit and feedback [11], small group
meetings [12], and academic detailing [13]. Systematic
reviews have established that in primary care and ambulatory practice, multi-faceted interventions that include
combinations of the above approaches [14] and active,
rather than passive, interventions [15] are the most successful in reducing antibiotic prescribing for inappropriate indications.
Unfortunately, the size of the effect of these approaches
has been limited. For instance, a UK randomised control trial incorporated the above principles in an intervention to reduce antibiotic prescribing by GPs [16].
This produced a modest decrease in antibiotic prescribing of 4.2 % in the intervention relative to the control
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practices. Moreover, the intervention was expensive and
cost £2923 per practice – several times the estimated annual savings in antibiotics cost. The European GRACE
consortium, however, showed an encouraging and likely
more affordable way to achieve meaningful reductions in
antibiotic prescribing for lower respiratory tract infections
[17]. This intervention used online training modules on
communication skills and on the use of C-reactive protein
(CRP) to distinguish bacterial from presumed viral infections. Both communication training and introduction of
CRP separately resulted in a reduction of antibiotic prescribing, with the combination achieving the largest effect
(communication intervention risk ratio: 0 · 68; CRP: 0 · 53;
combined intervention: 0 · 38) [18].
It is plausible that interventions targeted at an early,
receptive stage of GPs’ careers might be more efficacious. Early-career GPs may be a singularly appropriate
target for intervention. They are at a stage of their clinical
careers where their prescribing patterns are unlikely to be
firmly established and are thus more amenable to modification. Unlike hospital-based junior doctors, early-career
GPs are working in the clinical environment where they
will spend the rest of their careers, so education regarding long-term prescribing practices will be contextually
relevant. Because experienced clinicians have already
established consulting and antibiotic prescribing habits
that have been shown to be resistant to change [19], we
hypothesise that focused educational interventions that
target GPs in training whom are still developing their
own practice “style” and prescribing “habits”, could be
more effective in improving adherence to evidencebased guidelines.

Methods/design
The ChAP study (Changing the Antibiotic Prescribing
of general practice registrars) aims to improve the antibiotic prescribing of early-career GPs. In this study we
propose to develop an Australian educational intervention based on components of the INternet TRaining
for antibiOtic use (INTRO) intervention, developed in
Europe [17]. To assess the effectiveness of the intervention, ongoing quantitative data collection from the
Registrar Clinical Encounters in Training (ReCEnT)
Study will be utilized [20]. We will evaluate the intervention’s impact on antibiotic prescribing of earlycareer GPs for two classifications of respiratory tract
infections (URTI and acute bronchitis/bronchiolitis).
Study design

We will use a non-randomised non-equivalent control
group design. Data for the analyses will be collected
during the six-monthly rounds of ReCEnT data collection. The ReCEnT study is an ongoing prospective
multi-site cohort study of GP registrars/trainees'
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consultations in five of Australia’s 17 Australian GP regional training providers [20]. ReCEnT longitudinally
documents the nature and association of consultationbased clinical and educational experiences of earlycareer GPs (GP trainees). GP trainees record details of
60 consecutive consultations at approximately the midpoint of three six-month (full-time equivalent) terms
based in general practices. Details recorded include patient demographics, diagnoses/problems managed, medications prescribed, investigations ordered, and assistance
sought during the consultation (including supervisor advice and use of guidelines).

R21005 (sore throat). Codes R72001 (scarlet fever), R72003
(scarlatina) and R72004 (scarlet fever) will be excluded
from the analysis, as antibiotics are recommended for
all cases of these conditions in the authoritative Australian
guidelines [22].
We will define acute sinusitis as those presentations
coded as R75 (excluding R75003 and R75004 as these
are codes for chronic and allergic sinusitis respectively).
Acute otitis media will be defined as those presentations coded as H71 (excluding H71008, H710018 and
H710019 as these are codes for ear inflammation, abscess and mastoiditis).

Outcome measures
Primary outcomes

Setting

The primary outcomes will be
 Change in proportion of consultations (from pre-

intervention to post-intervention ReCEnT data
collection periods) for URTIs in which antibiotics
are prescribed
 Change in proportion of consultations (from preintervention to post-intervention ReCEnT data
collection periods) for bronchitis/bronchiolitis in
which antibiotics are prescribed.
Secondary outcomes

Secondary outcomes will be
 Change in proportion of consultations (from pre-

intervention to post-intervention ReCEnT data
collection periods) for bronchitis/bronchiolitis and
URTI (combined) in which antibiotics are
prescribed.
 Change in proportion of consultations (from preintervention to post-intervention ReCEnT data
collection periods) for sore throat in which
antibiotics are prescribed
 Change in proportion of consultations (from preintervention to post-intervention ReCEnT data
collection periods) for acute sinusitis in which
antibiotics are prescribed
 Change in proportion of consultations (from preintervention to post-intervention ReCEnT data
collection periods) for acute otitis media in which
antibiotics are prescribed
Respiratory tract infections will be defined by International Classification of Primary Care, 2nd Edition
(ICPC-2) disease diagnostic codes R74 (URTI) and R78
(bronchitis/bronchiolitis) [21].
We will define acute sore throat as the ICPC-2 codes R72
(strep throat), R76 (tonsillitis, acute), R74008 (pharyngitis,
acute), R74006 (infection, throat), R74017 (pharyngitis) and

The intervention will be delivered once to GP trainees in
two Regional Training Providers (RTPs). GP trainees in three
control training providers will receive usual educational activities. These are five of the 17 RTPs in the Australian general practice vocational training program. The demographics
of the GP trainees in the intervention group are broadly
comparable to those of the control training providers.
The intervention

The intervention in the ChAP study consists of four
components. The first three i.e. access to an online
introduction module, an online communication training
module, and an interactive workshop, are delivered separately to GP trainees and to supervisors. The fourth is
an optional joint GP trainee-supervisor activity, which
comprises a case-based discussion of evidence-based
antibiotic prescribing for each trainee-supervisor dyad in
their regular weekly one-on-one teaching meetings. An
overview of the study design and content of the intervention is provided in Fig. 1.
INTRO modules

The first two components (online introduction and communication training modules) are based on the INTRO
intervention. INTRO is part of a European multicountry study (GRACE consortium) aimed at reducing
inappropriate antibiotic prescribing for lower respiratory
tract infections in primary care [17]. One of the main
advantages of INTRO is that it is a brief and costeffective intervention. The introduction module discusses the need for reduced antibiotic prescribing and
the effect of over-prescription on the health care system,
patients and GPs. It covers the epidemiology of URTIs
in primary care, Australian and international antibiotic
use and antimicrobial resistance, and the evidence-base
of current clinical guidelines. The communication training module consists of videos showing how a GP can
use communication skills to elicit patient concerns and
expectations, discuss the pros and cons of antibiotic
treatment and the natural course of respiratory tract
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Fig. 1 Study design. ChAP study, Changing the Antibiotic Prescribing of general practice registrars; ReCEnT study, Registrar Clinical Encounters in
Training; URTIs, Upper Respiratory Tract Infections (upper respiratory tract infections and bronchitis/bronchiolitis); INTRO, INternet TRaining for
antibiOtic use

infections, whilst maintaining patient satisfaction. The
communication training module is supported by a patient booklet. These two modules were adapted for the
Australian context with particular reference to the
Australian Therapeutic Guidelines: Antibiotic. Version
15 (version 2013): TG [7].
The online modules will be made available to GP
trainees to work through individually at a time that best
suits them. They will be given a timeframe in which to
complete the modules. A face-to-face workshop will be
scheduled after completion of the electronic modules in
order to maximise the potential for effectiveness.
The INTRO modules will also be made available to
the trainee’s supervisors in the two intervention RTPs,
again prior to scheduled separate supervisor workshops
(see below).
Workshops

The workshop component consists of a 1.5 h interactive
workshop, scheduled as part of the standard training
program for GP trainees and delivered at the premises
of their RTP. We will use data on GP trainees' prescribing collected in the ReCEnT project to contextualise and
reinforce the practical relevance and importance of the
educational message (the ReCEnT data will be that of
the workshop attendee trainees and their more senior
colleagues who have been collecting ReCEnT data since
2010) [20]. During the workshop sessions, GP trainees
will be asked to reflect on their group’s prescribing data
and by means of clinical cases work through the main
principles of rational prescribing of antibiotics informed
by the authorative Australian guideline on antibiotic use
(eTG). During the workshop there will be room for

practising the communication skills presented in the online modules.
There will be ‘content’ discussion in the workshops,
which will expand upon and explore some of the issues
covered in the online modules. This discussion will
present URTIs and acute bronchitis as exemplars of respiratory tract infections for which antibiotics are rarely
indicated. Discussion will focus on these clinical syndromes, but the tenets of rational prescribing will also be
applied to other non-pneumonia respiratory tract infections for which antibiotics have very limited indications
(sore throat, acute otitis media, acute sinusitis).
Three underlying principles will inform the approach
presented in the discussion: Firstly, that the default
position for non-pneumonia respiratory tract infections is
to not prescribe antibiotics. Deviation from this principle
in any particular case requires careful consideration of the
rationale for prescribing in that individual patient’s circumstance. Secondly, treatment of non-pneumonia respiratory tract infections should be on syndromic rather
than aetiological basis. Delineation of viral versus bacterial
aetiology is difficult and non-contributory and does not
reflect current understanding of the complex interplay of
bacterial and viral pathogens [23, 24]. A syndromic approach to management reflects the empirical evidence for
treatment in the area [5, 25–27]. Thirdly, that the clinical
science of consultations for non-pneumonia respiratory
tract infections may be straightforward but managing patient expectations may be complex and require advanced
communication skills, i.e. the sophistication of consultation techniques employed should reflect the biopsychosocial complexity of the consultation rather than the
biological complexity of the clinical presentation.
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The workshop content will be constructed by the research team of GPs, GP vocational training educators, academic GPs and an infectious diseases physician/researcher.
The process will be informed by the current literature in
the area and our recent work in early-career GPs' antibiotic
prescribing – the prevalence and associations of antibiotic
prescribing for URTI and acute bronchitis/bronchiolitis
and the qualitative experiences of GP trainees in managing
URTI and acute bronchitis [9, 28].
The same workshop will be delivered separately to the
supervisors in the two intervention RTPs.
Joint trainee-supervisor activity

Each trainee-supervisor dyad will be encouraged to include a case-based discussion of evidence-based antibiotic
prescribing in their regular weekly one-on-one teaching
meetings. The supervisor will be offered a set of three or
four structured cases to include in the meeting. This activity will be optional as the content of trainee-supervisor
weekly meetings is at the discretion of the supervisors and
trainees rather than the RTP.
The rationale for supplementing the educational intervention with supervisor educational activities was that
our previous research suggested that the prescribing
patterns (role-modelling) of supervisors and the ‘apprenticeship’ model of the trainee-supervisor relationship are
drivers of non-rational antibiotic prescribing [9, 28].
Recruitment

All GP trainees at the five training providers complete ReCEnT data collection in each of their training terms. This
is part of their training program and includes reflection
on practice and future training directions via detailed
feedback [29]. The majority of GP trainees consent to the
data being used for research purposes. The intervention
will be conducted as part of their training program.
Sample size calculation

It is expected that the intervention group will consist of
approximately 130 GP trainees sourced from two intervention training providers and the control group of approximately 160 GP trainees from the control training
providers. Each of these GP trainees will provide data on
an average of four URTI consultations before the intervention and four URTI consultations after the intervention [9]. This will provide the study with approximately
80 % power to find an absolute reduction of 10 % in
antibiotic prescribing for URTIs in the intervention
group compared with the control group. This sample
size calculation takes into account an inflation factor of
1.9 derived from an intracluster correlation of 0.27 from
a similar study [12] and an anticipated proportion of
consultations for URTI of 8 % and expected pre-
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intervention rate of antibiotic prescribing of 22 % as
shown in the ReCEnT study [9].
Data collection and analysis

Change in antibiotic prescribing will be assessed via ReCEnT data pre- and post-intervention. The changes in
GP trainees’ prescribing will be compared with the
changes of GP trainees of the two regional training providers who are not receiving the intervention (control
group).
The principal analysis will be logistic regression within a
Generalised Estimating Equation framework to adjust for
clustering of observations within GP trainees. The unit of
analysis will be consultations involving a respiratory tract
infection and the outcome factor will be antibiotics prescribed (dichotomous). Independent variables in the
model will be treatment group (intervention/control),
time (before/after) and an interaction term of treatment
group by time. The p-value of the interaction term will be
used to determine statistical significance.
The dependent variables in regression models will be
consultations in which antibiotics are prescribed (for
URTI and acute bronchitis/bronchiolitis separately as
the primary outcomes, and for URTI plus acute bronchitis/bronchiolitis (combined), acute otitis media, acute
sinusitis and sore throat as the secondary outcomes).
We will also consider trainee, patient, practice and consultation related factors in the regression analyses. GP
trainee factors will be age, gender, training term, place of
medical qualification (Australia/international), and fulltime/part-time status. Patient factors will be age, gender,
Indigenous (Aboriginal or Torres Strait Islander) status,
Non-English-speaking background status, whether new
patient to the practice, and whether a new patient to the
GP trainee. Practice factors will be rurality/urbanicity, socioeconomic status of the practice location, and practice
size (number of GPs). Practice postcode will be used to assign the Australian Standard Geographical ClassificationRemoteness Area (ASGC-RA) classification (the degree of
rurality) of the practice location [30] and to define the
practice location’s Socioeconomic Index for Area (SEIFA)
Relative Index of Disadvantage [31]. Consultation factors
will include the number of diagnoses/problems dealt with
during the consultation, if the problem was a new one,
and if the GP trainee sought clinical assistance during the
consultation (from their supervisor/trainer, from a specialist, or from electronic or hard-copy resources).
Primary analyses will be by intention to treat (data
of all GP trainees in the intervention group will be
analysed irrespective of whether they attended the
intervention workshop). We will also analyse the per
protocol data (of only those GP trainees who attend the
workshop) and compare these with the intention to treat
analysis.
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Qualitative study

In addition, GP trainees and supervisors who participated in the intervention, will be invited to take part in a
telephone interview after the full ChAP intervention has
been delivered. Interview questions will focus on the acceptability and utility of the intervention components,
the elements that changed practice, and suggestions for
improvement. All interviews will be recorded digitally
and transcribed verbatim. Two researchers will independently code the interviews, compare their coding and
discuss discrepancies. Interview data will be analysed
using thematic analysis [32]. An iterative process will be
used to develop the final thematic framework.
Funding and ethics

This study is funded by a competitive research grant of
the Therapeutic Guidelines Limited and the Royal Australian College of General Practitioners. Funding was
awarded after a peer-review process assessing the importance, scientific quality, and originality of the study. The
intervention is registered in the Australian New Zealand
Clinical Trials Registry (ACTRN12614001209684).
The wider ReCEnT project is funded by the five participating Regional Training Providers. These organisations
are funded by General Practice Education and Training,
an Australian Commonwealth Government initiative.
This study was approved by the Human Research Ethics
Committee from the University of Newcastle (H-20090323) and The University of Queensland (2014000743).
Confidentiality will be ensured by the current practice
regarding ReCEnT data. All ReCEnT data collection is deidentified. Registrations can only be linked to the same
early-career GP through a coding system. The key to this
code is not known to the investigators and kept separately
in a locked filing cabinet and password protected computer file at the regional training providers where the data
are collected.
Following the completion of the study, the intervention will be offered to the control training providers and
be made available to other Australian regional training
providers (Additional file 1).

Discussion
Experienced clinicians have already established distinct
consulting and prescribing habits, which have been
shown to be resistant to change [19]. Interventions on
antibiotic prescribing have a modest effect [16]. In the
proposed study we target educational interventions to
early-career GPs when they are still developing their own
prescribing “style” and “habits”. This approach could be
more effective in improving adherence to evidence-based
guidelines.
Delivering educational interventions to early-career
GPs rather than established GPs may also be a more
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efficient and sustainable way to educate prescribers about
evidence-based use of antibiotics. Australian early-career
GPs are engaged in an educational program during release
days from their practice, in parallel with their practicebased training. Face-to-face educational activities, as well
as access to web-based support, could be delivered within
the context of their existing educational program. The
infrastructure to deliver the intervention already exists.
Use of this infrastructure would avoid the organisational
demands of staging individual practice seminars and setting up dedicated web-based support systems. This study
will produce a template for an educational model targeting
clinicians/prescribers in the early stages of their careers.
The impact of the educational intervention will be evaluated by the ReCEnT study, thereby allowing an efficient
integration with a concurrent education and research project [19]. Moreover, whilst this intervention focuses on adherence to guidelines for rational prescribing of antibiotics
in respiratory tract infections in the general practice
setting, it has the potential to serve as a generic model to
enhance uptake of therapeutic guideline recommendations in general.
One limitation of the study is that it will not be possible to ascertain the appropriateness of prescription of
antibiotics in any single clinical encounter. For example,
in bronchitis where antibiotic prescription is discouraged
for the great majority of patients, antibiotics may be
appropriate for those with severe co-morbid conditions
and immunosuppression [7]. However, overall antibiotic
prescribing for non-pneumonia acute respiratory tract infections, and for each individual condition, is still a robust
measure of appropriate prescribing at the macro-level and
has been used in numerous previous studies [12–17].
A further consideration is that prescription is not necessarily followed by dispensing (filling the script), or
even consumption of antibiotics by the patient. In our
study we will ascertain prescription of antibiotics only.
An advantage of our methodology is that we also capture the indication for prescribing, as compared with
other studies, which report total, non-disease-specific
dispensing [16]. As the focus of this intervention is
rational prescribing of antibiotics in acute URTIs and
acute bronchitis/bronchiolitis, measuring indicationspecific prescribing will provide the most appropriate
indicator of the impact of the intervention. If the intervention is successful, further studies could assess the
impact of a reduction in prescribing on overall dispensing and consumption of antibiotics and antimicrobial
resistance rates.
The multimodal and multifaceted model developed
from the ChAP study can also be used in programs targeting established GPs and inform effective interventions
to curb the growth of antimicrobial resistance through
rational prescribing of an increasingly precious resource.
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Additional file
Additional file 1: TIDieR (Template for Intervention Description and
Replication) checklist. (PDF 120 kb)
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